The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD

Trial Profile

The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2015

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Jun 2012 Actual patient number is 30 according to ClinicalTrials.gov.
    • 20 Jun 2012 Actual initiation date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 20 Jun 2012 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top